SCHEMBL17346

SCHEMBL17346

C[C@H]1CN(S(=O)(=O)c2ccccc2)CCN1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.51
POLB P06746 1/20 0.51
CYP3A4 P08684 1/20 0.51
CYP2D6 P10635 1/20 0.51
NFKB1 P19838 1/20 0.51
PRKD3 O94806 1/20 0.51
PRKCG P05129 1/20 0.51
PRKCB P05771 1/20 0.51
PRKCA P17252 1/20 0.51
PRKCH P24723 1/20 0.51
PRKCI P41743 1/20 0.51
PRKCE Q02156 1/20 0.51
PRKCQ Q04759 1/20 0.51
PRKCZ Q05513 1/20 0.51
PRKCD Q05655 1/20 0.51
PRKD1 Q15139 1/20 0.51
ALDH1A1 P00352 5/20 0.49
TP53 P04637 1/20 0.49
GAA P10253 1/20 0.47
PKM P14618 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL16426 0.98 L3MBTL1 (0.50) L3MBTL1POLBCYP3A4CYP2D6NFKB1
Hydrochloric Acid SCHEMBL16427 0.98 L3MBTL1 (0.50) L3MBTL1POLBCYP3A4CYP2D6NFKB1
SCHEMBL31381384 0.89 CYP3A4 (0.53) CYP3A4CYP2D6NFKB1PRKD3PRKCG
Hydrochloric Acid SCHEMBL26668501 0.88 CYP3A4 (0.52) CYP3A4CYP2D6NFKB1PRKD3PRKCG
Hydrochloric Acid SCHEMBL26668506 0.88 CYP3A4 (0.52) CYP3A4CYP2D6NFKB1PRKD3PRKCG
SCHEMBL5250746 0.84 MAPT (0.62) L3MBTL1POLBCYP3A4CYP2D6NFKB1
SCHEMBL3710334 0.84 MAPT (0.62) L3MBTL1POLBCYP3A4CYP2D6NFKB1
SCHEMBL28201970 0.84 GLA (0.54) POLBCYP3A4CYP2D6NFKB1PRKD3
SCHEMBL1944641 0.84 MAPT (0.62) L3MBTL1POLBCYP3A4CYP2D6NFKB1
SCHEMBL6181724 0.83 PKM (0.66) CYP3A4CYP2D6NFKB1PRKD3PRKCG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8431563-B2 Compounds that interact with glucokinase regulatory protein for the treatment of diabetes AMGEN INC. (US) 2013-04-30 US disclosed
US-20120225854-A1 COMPOUNDS THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES AMGEN INC. (US) 2012-09-06 US disclosed
WO-2012027261-A1 SULFONYLPIPERAZINE DERIVATIVES THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES AMGEN INC. (US) 2012-03-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120225854-A1 COMPOUNDS THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES GCKR, GCK, SLC5A2 L3MBTL1 4623/4885POLB 4613/4885CYP3A4 1914/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.